| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |